Autophagosome-Mediated EGFR Down-Regulation Induced by the CK2 Inhibitor Enhances the Efficacy of EGFR-TKI on EGFR-Mutant Lung Cancer Cells with Resistance by T790MKwang Sup So(University of Ulsan), Jae Cheol Lee(Ulsan College)PLoS ONEDecember 8, 201410.1371/journal.pone.0114000Cited by 28SaveCiteExport RISWatch citationsRelated PapersActivation of the IGF1R pathway potentially mediates acquired resistance to mutant-selective 3rd-generation EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer|Oncotarget|2016|70Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer|Nature Cancer|2023|46Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors|PLoS ONE|2013|11